Kolmar BioTech. Inc. 215380

KRX · South Korea · Process Industries

KRW 2,320.00+35.00 (+1.53%)

Market closed· Oct 2, 2026, 6:30 AM UTC· KRW · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

Kolmar BioTech. Inc. 215380

KRX · South Korea · Process Industries

KRW 2,320.00+35.00 (+1.53%)

Market closed· Oct 2, 2026, 6:30 AM UTC· KRW · Data may be delayed

Company news

Yahoo FinanceJan 06, 2026

Xellar and WOOJUNG BIO Announce Multi-Year Strategic Partnership to Advance AI-Enabled Hybrid Human Organ-on-a-Chip (OoC)-Animal Preclinical Platforms

Xellar Biosystems ("Xellar"), a globally leading innovator in next-generation artificial intelligence- and computer vision–assisted, organ-on-a-chip–based drug discovery and development platforms, today announced that it has entered into a multi-year strategic collaboration agreement with WOOJUNG BIO Co., Ltd. ("WOOJUNG BIO"; KOSDAQ: 215380), a Korea-listed biotechnology company with strong capabilities in translational research and life sciences services.

Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.

Prices may be delayed and are for informational purposes only - not investment advice.